- Home
- WHWK vs OVID Comparison
WHWK vs OVID Comparison
Compare WHWK & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- OVID
- Stock Information
- Founded
- WHWK 2007
- OVID 2014
- Country
- WHWK United States
- OVID United States
- Employees
- WHWK N/A
- OVID N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- WHWK Health Care
- OVID Health Care
- Exchange
- WHWK Nasdaq
- OVID Nasdaq
- Market Cap
- WHWK 82.4M
- OVID 88.9M
- IPO Year
- WHWK N/A
- OVID 2017
- Fundamental
- Price
- WHWK $1.95
- OVID $1.14
- Analyst Decision
- WHWK
- OVID Strong Buy
- Analyst Count
- WHWK 0
- OVID 4
- Target Price
- WHWK N/A
- OVID $3.13
- AVG Volume (30 Days)
- WHWK 122.3K
- OVID 1.5M
- Earning Date
- WHWK 11-15-2025
- OVID 11-11-2025
- Dividend Yield
- WHWK N/A
- OVID N/A
- EPS Growth
- WHWK N/A
- OVID N/A
- EPS
- WHWK N/A
- OVID N/A
- Revenue
- WHWK $21,596,000.00
- OVID $6,651,000.00
- Revenue This Year
- WHWK N/A
- OVID $708.13
- Revenue Next Year
- WHWK N/A
- OVID N/A
- P/E Ratio
- WHWK N/A
- OVID N/A
- Revenue Growth
- WHWK N/A
- OVID 1070.95
- 52 Week Low
- WHWK $1.39
- OVID $0.24
- 52 Week High
- WHWK $3.81
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- WHWK 53.17
- OVID 52.94
- Support Level
- WHWK N/A
- OVID N/A
- Resistance Level
- WHWK $2.04
- OVID $1.35
- Average True Range (ATR)
- WHWK 0.09
- OVID 0.11
- MACD
- WHWK -0.05
- OVID -0.08
- Stochastic Oscillator
- WHWK 95.59
- OVID 84.44
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.